27 Results for "

radiosensitivity

" in MedChemExpress (MCE) Product Catalog:
Products (27)

27 Results for "radiosensitivity" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-13299
CAS No.: 1001917-37-8
Purity:  98.34%
Target:  

c-Met/HGFR

Research Areas:  

Cancer

MK-8033 is an orally active ATP competitive c-Met/Ron dual inhibitor (IC50s: 1 nM (c-Met),7 nM (Ron)), with preferential binding to the activated kinase conformation. MK-8033 can be used in the research of cancers, such as breast and bladder cancers, non-small cell lung cancers (NSCLCs) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-13299A
CAS No.: 1283000-43-0
Purity:  99.86%
Target:  

c-Met/HGFR

Research Areas:  

Cancer

MK-8033 hydrochloride is an orally active ATP competitive c-Met/Ron dual inhibitor (IC50s: 1 nM (c-Met),7 nM (Ron)), with preferential binding to the activated kinase conformation. MK-8033 hydrochloride can be used in the research of cancers, such as breast and bladder cancers, non-small cell lung cancers (NSCLCs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-134594
CAS No.: 2416910-69-3
Purity:  99.55%
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

SENP1-IN-1 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 29. SENP1-IN-1 is developed for tumor radiosensitivity enhancement .
loading...
    loading...
Cat. No.: HY-162002
CAS No.: 2765448-96-0
Target:  

ATM/ATR

Research Areas:  

Cancer

WSD0628 is a brain penetrant and potent ATM inhibitor with profound radiosensitizing effect .
loading...
    loading...
Cat. No.: HY-N4327
CAS No.: 23062-24-0
Eurycomalactone is an active quassinoid could be isolated from Eurycoma longifolia Jack. Eurycomalactone is a potent NF-κB inhibitor with an IC50 value of 0.5 μM. Eurycomalactone inhibits protein synthesis and depletes cyclin D1. Eurycomalactone enhances radiosensitivity through arrest cell cycle at G2/M phase and delayed DNA double-strand break repair. Eurycomalactone inhibits the activation of AKT/NF-κB signaling, induces apoptosis and enhances chemosensitivity to Cisplatin (HY-17394) .
loading...
    loading...
Cat. No.: HY-100683
CAS No.: 1005129-80-5
Purity:  98.0%
Target:  

Phosphatase

Research Areas:  

Cancer

A12B4C3 is a potent human polynucleotide kinase/phosphatase (hPNKP) inhibitor with an IC50 value of 0.06 μM. A12B4C3 has antiproliferative activity against cancer cells. A12B4C3 can also enhance the radiosensitivity of certain cancer cells .
loading...
    loading...
Cat. No.: HY-W008449
CAS No.: 6136-37-4
1-Methylxanthine, a caffeine derivative, is an essential human urinary metabolite of caffeine and theophylline (1,3-dimethylxanthine, TP) . 1-Methylxanthine enhances the radiosensitivity of tumor cells .
loading...
    loading...
Cat. No.: HY-13540
CAS No.: 902128-92-1
Purity:  98.46%
Synonyms: GPI 21016
Target:  

PARP

Research Areas:  

Cancer

E7016 (GPI 21016) is an orally available PARP inhibitor. E7016 can enhance tumor cell radiosensitivity in vitro and in vivo through the inhibition of DNA repair. E7016 acts as a potential anticancer agent .
loading...
    loading...
Cat. No.: HY-134596
CAS No.: 2416910-59-1
Purity:  99.92%
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

SENP1-IN-3 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 17. SENP1-IN-3 is developed for tumor radiosensitivity enhancement .
loading...
    loading...
Cat. No.: HY-176798
CAS No.: 1964516-64-0
NCI-006 is an orally active lactate dehydrogenase (LDH) inhibitor (LDHA IC50 = 0.06 μM; LDHB IC50 = 0.03 μM). NCI-006 inhibits intratumoral LDH activity, lactate production, and tumor growth in a mouse pancreatic cancer model. NCI-006 inhibits glycolysis and induces apoptosis in vitro. NCI-006 enhances the radiosensitivity of glycolytic tumor cell lines while sparing non-glycolytic/normal cells (1522, skin fibroblasts) in combination with ionizing radiation (IR). NCI-006 exhibits synergistic antitumor effects in combination with IACS-010759 (HY-112037) against colorectal and gastric cancers. NCI-006 targets glycolysis by inhibiting lactate dehydrogenase impairs tumor growth in an Ewing sarcoma model .
loading...
    loading...
Cat. No.: HY-134597
CAS No.: 2416910-64-8
Purity:  ≥98.0%
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

SENP1-IN-4 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 21. SENP1-IN-4 is developed for tumor radiosensitivity enhancement .
loading...
    loading...
Cat. No.: HY-139289S
CAS No.: 2607139-85-3
ART899 is a highly specific allosteric inhibitor of the Polθ DNA polymerase domain. ART899 can effectively enhance the radiosensitivity of tumor cells, shows good tolerance when combined with fractionated radiation, and significantly reduces tumor growth compared to radiation alone .
loading...
    loading...
Cat. No.: HY-106509
CAS No.: 77858-21-0
Purity:  99.59%
Synonyms: BW 12C; 12C79; BW 12C79
Target:  

Hemoglobin

Research Areas:  

Cardiovascular Disease Cancer

Velaresol (BW 12C) is a small molecule oxyhemoglobin stabilizer. Velaresol stabilizes hemoglobin’s oxy-conformation, shifts oxygen dissociation curves left, induces tumor hypoxia, alters radiosensitivity, protects normal tissues from radiation damage, and reduces sickled cell counts. Velaresol can be used for the research of cancer and sickle cell disease .
loading...
    loading...
Cat. No.: HY-116428
CAS No.: 160141-09-3
Research Areas:  

Cancer

L-744832 is a farnesyl transferase inhibitor. L-744832 effectively inhibits the farnesylation of H-Ras and N-Ras, but has little effect on K-Ras treatment. L-744832 not only directly targets the oncogenic pathway by inhibiting Ras farnesylation, but also enhances radiosensitivity by restoring TGF-β signaling through epigenetic reprogramming. L-744832 can induce cell cycle arrest and apoptosis. L-744832 can be used in combination therapy studies for Ras-driven tumors such as pancreatic cancer .
loading...
    loading...
Cat. No.: HY-134595
CAS No.: 2416910-70-6
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

SENP1-IN-2 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 30. SENP1-IN-2 is developed for tumor radiosensitivity enhancement .
loading...
    loading...
Cat. No.: HY-120429
CAS No.: 1255099-06-9
Target:  

Apoptosis

Research Areas:  

Cancer

SKLB-163 is an orally active inhibitor for Rho GDP-dissociation (RhoGDI). SKLB-163 inhibits highly expressed RhoGDI tumor cell proliferation and migration, and increases radiosensitivity of tumor cells. SKLB-163 induces cancer cell Apoptosis .
loading...
    loading...
Cat. No.: HY-122759
CAS No.: 16961-77-6
Research Areas:  

Cancer

CPA7 is a novel Stat3 inhibitor. CPA7 downregulates survivin, Bcl-XL, and Mcl-1. CPA7 induces Apoptosis. CPA7 enhances the radiosensitivity of prostate cancer. CPA7 has anti-cancer effects against prostate cancer .
loading...
    loading...
Cat. No.: HY-W008449S
1-Methylxanthine- 13C,d3 is the 13C- and deuterium labeled 1-Methylxanthine. 1-Methylxanthine, a caffeine derivative, is an essential human urinary metabolite of caffeine and theophylline (1,3-dimethylxanthine, TP) . 1-Methylxanthine enhances the radiosensitivity of tumor cells .
loading...
    loading...
Cat. No.: HY-164539
CAS No.: 2231800-32-9
Target:  

HDAC Autophagy

Research Areas:  

Cancer

TMU 35435 is a histone deacetylase (HDAC) inhibitor. TMU-35435 inhibits the NHEJ pathway through ubiquitination of DNA-dependent protein kinase catalytic subunit (DNA-PKcs). In addition, TMU 35435 enhances radiosensitivity by inducing misfolded protein aggregation and autophagy in TNBC .
loading...
    loading...
Cat. No.: HY-121648
CAS No.: 140448-29-9
Research Areas:  

Cancer

PK 130 is a 2-nitroimidazole derivative that has radiosensitizing effects on hypoxic cells. PK 130 increases the radiosensitivity of Chinese hamster V79 cells under hypoxic conditions .
loading...
    loading...